Products & Alliances
PrEP Biopharm Ltd
hVIVO Innovation Areas
CHALLENGE STUDY SERVICES
TARGET & BIOMARKER DISCOVERY
Aim Rule 26
Press and Media Contact
experimental influenza virus challenge
human monoclonal antibody
hVIVO challenge model
influenza disease model
TCN-032; anti-M2e antibody; influenza viral challenge. influenza rsearch
Scientific Papers: rsv
Scientific Paper 97: Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals.
Scientific Paper 89 : A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus.
Scientific Paper 107 : Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study
Scientific Paper 72 : A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV.
Scientific Paper 65 : Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine.
Scientific Paper 23 : Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
Scientific Paper 34 : Longitudinal study of an epitope-biased serum haemagglutination-inhibition antibody response in rabbits immunized with type A influenza virions.
Scientific Paper 57 : The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
Scientific Paper 88 : Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans.
Scientific Paper 98 : Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections.